Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2019 - 2025)

Historic Amortization of Deferred Charges for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Q3 2025 value amounting to $885000.0.

  • Amphastar Pharmaceuticals' Amortization of Deferred Charges rose 1895.16% to $885000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 6091.72%. This contributed to the annual value of $6.0 million for FY2024, which is 4708.31% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Amortization of Deferred Charges stood at $885000.0 for Q3 2025, which was up 1895.16% from $842000.0 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Amortization of Deferred Charges registered a high of $5.2 million during Q3 2023, and its lowest value of -$2.3 million during Q4 2021.
  • For the 5-year period, Amphastar Pharmaceuticals' Amortization of Deferred Charges averaged around $1.2 million, with its median value being $826000.0 (2021).
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Amortization of Deferred Charges plummeted by 33458.33% in 2021 and then surged by 961000.0% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Amortization of Deferred Charges (Quarter) stood at -$2.3 million in 2021, then skyrocketed by 101.33% to $30000.0 in 2022, then surged by 9610.0% to $2.9 million in 2023, then plummeted by 75.15% to $724000.0 in 2024, then grew by 22.24% to $885000.0 in 2025.
  • Its Amortization of Deferred Charges was $885000.0 in Q3 2025, compared to $842000.0 in Q2 2025 and $762000.0 in Q1 2025.